Intelligent Bio Solutions Inc. (INBS) stock
INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3058% below fair value
$1.56+0.06 (+4.00%)
Close on Nov 17, 2026Market cap $4.72MP/E –Yield –
Intelligent Bio Solutions total assets
Total assets on the balance sheet at the end of each period.
Intelligent Bio Solutions's total assets was $11.94M at Jun 30, 2026. For fiscal 2026 it was $11.94M, up 44.8% from the year before. The highest annual figure on record is $21.86M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $11.94M | +44.8% |
| FY2025 | Jun 30, 2025 | $8.25M | -40.1% |
| FY2024 | Jun 30, 2024 | $13.78M | +33.1% |
| FY2023 | Jun 30, 2023 | $10.35M | -16.2% |
| FY2022 | Jun 30, 2022 | $12.35M | -43.5% |
| FY2021 | Jun 30, 2021 | $21.86M | +783.0% |
| FY2020 | Jun 30, 2020 | $2.48M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $11.94M | +44.8% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $14.86M | +55.1% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $17.65M | +103.3% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $10.04M | -14.4% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $8.25M | -40.1% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $9.58M | -43.7% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $8.68M | -1.6% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $11.73M | +34.8% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $13.78M | +33.1% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $17.04M | +59.7% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $8.83M | -51.1% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $8.70M | -14.4% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $10.35M | -16.2% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $10.67M | -25.7% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $18.05M | +18.5% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $10.16M | -46.8% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $12.35M | -43.5% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $14.36M | -17.7% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $15.24M | -23.7% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $19.11M | +671.8% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $21.86M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $17.45M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $19.97M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $2.48M | – |
See a number that looks wrong?